Considering how many BC patients actually die of blood clots

jenrio

Considering how many BC patients actually die of blood clots, this new drug is very interesting:

http://www.bloomberg.com/news/2012-12-08/blood-thinner-from-pfizer-bristol-myers-blocks-leg-clots.html

Outfield

Wait for it to come out with full info before any excitement.  Pradaxa (rivaroxaban) sounded great when one sentence was used to describe it.  True, it needs no monitoring.  True, dosing is easy.  But also true, unlike Coumadin, there is NO way to reverse its effect.  So say you've been taking it to prevent a clot in the heart that can cause a stroke  (it is approved for atrial fibrillation, a common situation that predisposes to clots in the heart), you're doing fine, then you're in a car accident and sustained some internal injuries, or you fall and hit your head and have a mild subdural bleeder.  Much, much worse situation then than if you have been taking Coumadin or heparin, and can just get FFP and/or Vitamin K.

jenrio

I c.   It obvious needs more work, more data.   All the complications of cancers (blood clots/bleeding/necrosis etc) need better drug management to save people's lives.